Intratumoural heterogeneity of intestinal expression reflects environmental induction and progression-related loss of induction in undifferentiated-type gastric carcinomas

Histopathology

Volumn 53, Issue 6, 2008, Pages 685-697

  Natsagdorj, L ^a   Sugihara, H ^a   Bamba, M ^a   Hattori, T ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Cdx2; MUC2; Tissue environment; Tumour progression; Undifferentiated type gastric carcinoma

Indexed keywords

MUCIN 2; MUCIN 5AC; MUCIN 6; TRANSCRIPTION FACTOR CDX2;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL HETEROGENEITY; CELL POLARITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; PRIORITY JOURNAL; SIGNET RING CARCINOMA; STOMACH CARCINOMA; TISSUE INDUCTION;

ADULT; AGED; CARCINOMA; CELL DIFFERENTIATION; ENVIRONMENT; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINES; MIDDLE AGED; MUCIN 5AC; MUCIN-2; MUCIN-6; STOMACH; STOMACH NEOPLASMS;

EID: 57049113143     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03166.x     Document Type: Article

References (29)

1. Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta. Pathol. Microbiol. Scand. 1965 6 31 49.
2. Carneiro F. Classification of gastric carcinomas. Curr. Diagn. Pathol. 1997 4 51 59.
3. Japanese Research Society of Gastric Cancer. Japanese Classification of Gastric Carcinoma, English ed. Tokyo : Kanehara, 1995.
4. Kushima R, Jancic S, Hattori T. Association between expression of sialosyl-Tn antigen and intestinalization of gastric carcinomas. Int. J. Cancer 1993 55 904 908.
5. Yamachika T, Inada K, Fujimitsu Y et al. Intestinalization of gastric signet ring cell carcinomas with progression. Virchows Arch. 1997 431 103 110.
6. Bamba M, Sugihara H, Kushima R et al. Time-dependent expression of intestinal phenotype in signet ring cell carcinomas of the human stomach. Virchows Arch. 2001 438 49 56.
7. Maekita T, Nakazawa K, Mihara M et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin. Cancer Res. 2006 12 989 995.
8. Yuasa Y, Nagasaki H, Akiyama Y et al. Relationship between CDX2 gene methylation and dietary factors in gastric cancer patients. Carcinogenesis 2005 26 193 200.
9. Brabletz T, Spaderna S, Kolb J et al. Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: an active role for the tumor environment in malignant tumor progression. Cancer Res. 2004 64 6973 6977.
10. Benahmed F, Gross I, Guenot D et al. The microenvironment controls CDX2 homeobox gene expression in colorectal cancer cells. Am. J. Pathol. 2007 170 733 744.
11. Yamamoto H, Bai YQ, Yuasa Y. Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression. Biochem. Biophys. Res. Commun. 2003 300 813 818.
12. Faller G, Dimmler A, Rau T et al. Evidence for acid-induced loss of Cdx2 expression in duodenal gastric metaplasia. J. Pathol. 2004 203 904 908.
13. Saito A, Shimoda T, Nakanishi Y, Ochiai A, Toda G. Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Pathol. Int. 2001 51 165 171.
14. Peng DF, Sugihara H, Mukaisho K, Tsubosa Y, Hattori T. Alterations of chromosomal copy number during progression of diffuse-type gastric carcinomas: metaphase- and array-based comparative genomic hybridization analyses of multiple samples from individual tumours. J. Pathol. 2003 201 439 450.
15. Peng DF, Sugihara H, Mukaisho K, Ling ZQ, Hattori T. Genetic lineage of poorly differentiated gastric carcinoma with a tubular component analysed by comparative genomic hybridization. J. Pathol. 2004 203 884 895.
16. Yoshimura A, Sugihara H, Ling ZQ et al. How wild-type TP53 is inactivated in undifferentiated-type gastric carcinomas: analyses of intratumoral heterogeneity in deletion and mutation of TP53. Pathobiology 2006 73 40 49.
17. Sugihara H, Hattori T, Imamura Y et al. Morphology and modes of cell proliferation in earliest signet-ring-cell carcinomas induced in canine stomachs by N-ethyl-N'-nitro-N-nitrosoguanidine. J. Cancer Res. Clin. Oncol. 1991 117 197 204.
18. Sugihara H, Hattori T, Fukuda M, Fujita S. Cell proliferation and differentiation in intramucosal and advanced signet ring cell carcinomas of the human stomach. Virchows Arch. A Pathol. Anat. Histopathol. 1987 411 117 127.
19. Machado JC, Nogueira AM, Carneiro F, Reis CA, Sobrinho-Simões M. Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J. Pathol. 2000 190 437 443.
20. Nakamura E, Sugihara H, Bamba M, Hattori T. Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas. J. Pathol. 2005 205 349 358.
21. Mizoshita T, Tsukamoto T, Nakanishi H et al. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J. Cancer Res. Clin. Oncol. 2003 129 727 734.
22. Liu Q, Teh M, Ito K, Shah N, Ito Y, Yeoh KG. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer. Mod. Pathol. 2007 20 1286 1297.
23. Sugai T, Habano W, Uesugi N et al. Three independent genetic profiles based on mucin expression in early differentiated-type gastric cancers - a new concept of genetic carcinogenesis of early differentiated-type adenocarcinomas. Mod. Pathol. 2004 17 1223 1234.
24. Nakamura T, Yao T, Kabashima A, Nishiyama K, Maehara Y, Tsuneyoshi M. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma. Histopathology 2005 47 357 367.
25. Endoh Y, Sakata K, Tamura G et al. Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J. Pathol. 2001 191 257 263.
26. Tajima Y, Yamazaki K, Makino R et al. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background. Clin. Cancer Res. 2006 12 6469 6479.
27. Baldus SE, Zirbes TK, Engel S et al. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas. Int. J. Cancer 1998 79 133 138.
28. Utsunomiya T, Yonezawa S, Sakamoto H et al. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Clin. Cancer Res. 1998 4 2605 2614.
29. Fan Z, Li J, Dong B, Huang X. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis. Clin. Cancer Res. 2005 11 6162 6170.